Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

An integrated CRISPR/iPSC-based approach to elucidate uncertain variation in RPE65, a target for gene therapy

Information

Project Team

Outputs and Outcomes

Publications

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

Eline Van VoorenSuzanne KohlCarlo RivoltaBart LeroyMiriam BauwensElfride De Baere

C3 Conference

2023

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

Eline Van VoorenSuzanne KohlCarlo RivoltaBart LeroyMiriam BauwensElfride De Baere

C3 Conference

2023

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

Eline Van VoorenSuzanne KohlBart LeroyMiriam BauwensElfride De Baere

C3 Conference

2022